Chitosan Nanoparticles for Enhanced Immune Response and Delivery of Multi-Epitope <i>Helicobacter pylori</i> Vaccines in a BALB/c Mouse Model
<b>Background/Objectives</b>: <i>Helicobacter pylori</i> is the leading cause of chronic gastritis, peptic ulcer, gastric adenocarcinoma, and mucosal-associated lymphoma. Due to the emerging problems with antibiotic treatment against <i>H. pylori</i> in clinical p...
Saved in:
Main Authors: | Rita Amaral, Tomás Concha, Jorge Vítor, António J. Almeida, Cecília Calado, Lídia M. Gonçalves |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-01-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/17/1/132 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current prevalence of Helicobacter pylori infection in patients with dyspepsia treated in Warsaw, Poland
by: Tadeusz Tacikowski, et al.
Published: (2017-05-01) -
The Main Statements of the Consensus “Maastricht-VI” (2022) on the Diagnostics and Treatment of <i>Helicobacter pylori</i> Infection
by: A. A. Sheptulin
Published: (2023-02-01) -
<i>Helicobacter pylori</i> HP0135 Is a Small Lipoprotein That Has a Role in Outer Membrane Stability
by: Doreen Nguyen, et al.
Published: (2025-01-01) -
Pivotal role of Helicobacter pylori virulence genes in pathogenicity and vaccine development
by: Ayman Elbehiry, et al.
Published: (2025-01-01) -
Gastric Microbiota Associated with Gastric Precancerous Lesions in <i>Helicobacter pylori</i>-Negative Patients
by: Han-Na Kim, et al.
Published: (2025-01-01)